PFIZER INC.
- Country
- 🇺🇸United States
- Ownership
- Public
- Established
- 1849-01-01
- Employees
- 88K
- Market Cap
- $163.3B
- Website
- http://www.pfizer.com
Use and Effectiveness of COVID-19 Vaccines Using State Vaccine Registries and Insurance Claims Data
- Conditions
- Interventions
- First Posted Date
- 2023-05-25
- Last Posted Date
- 2024-12-18
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 999
- Registration Number
- NCT05876377
- Locations
- 🇺🇸
Pfizer, New York, New York, United States
A Study to Learn About the Safety and Immune Response of 20vPnC in Adults in India.
- Conditions
- Interventions
- First Posted Date
- 2023-05-25
- Last Posted Date
- 2024-10-24
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 405
- Registration Number
- NCT05875727
- Locations
- 🇮🇳
Jawahar Lal Nehru Hospital, Ajmer, Rajasthan, India
🇮🇳Jawahar Lal Nehru Medical College, Ajmer, Rajasthan, India
🇮🇳Nirmal Hospital Pvt Ltd., Surat, Gujarat, India
A Study to Learn About Effect of Sisunatovir in Healthy Adult Male Participants
- Conditions
- Interventions
- First Posted Date
- 2023-05-24
- Last Posted Date
- 2024-05-16
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 9
- Registration Number
- NCT05873764
- Locations
- 🇺🇸
Pharmaron Clinical Pharmacology Center, Baltimore, Maryland, United States
A Study to Learn About How Trumenba Vaccine Shots Work Against Gonorrhea Infection in Teenagers and Young Adults in the United States.
- Conditions
- Interventions
- First Posted Date
- 2023-05-24
- Last Posted Date
- 2024-02-26
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 999
- Registration Number
- NCT05873751
- Locations
- 🇺🇸
Pfizer, New York, New York, United States
A Study to Learn About the First and Later Lines of Medicines in Treating People With Metastatic Renal Cell Carcinoma (mRCC).
- Conditions
- First Posted Date
- 2023-05-15
- Last Posted Date
- 2023-05-15
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 494
- Registration Number
- NCT05858749
- Locations
- 🇺🇸
Pfizer Headquarters, New York, New York, United States
This Study Intends to Describe the Characteristics of Patients Given the Pfizer-BioNTech Bivalent mRNA COVID-19 Vaccine and Any Commercially Available Influenza Vaccines at the Same Time Versus at Different Times.
- Conditions
- Interventions
- First Posted Date
- 2023-05-15
- Last Posted Date
- 2023-06-01
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 1
- Registration Number
- NCT05858450
- Locations
- 🇺🇸
Pfizer, New York, New York, United States
A Study to Compare How the Study Medicine (PF-07923568) is Processed in Participants With Different Levels of Loss of Liver Function to Healthy Participants.
- First Posted Date
- 2023-05-12
- Last Posted Date
- 2024-04-03
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 28
- Registration Number
- NCT05857644
- Locations
- 🇺🇸
Orlando Clinical Research Center, Orlando, Florida, United States
🇺🇸Orange County Research Center, Tustin, California, United States
🇺🇸Genesis Clinical Research, LLC, Tampa, Florida, United States
A Study to Assess Two Forms of The Study Medicine (Ritlecitinib) in Healthy Adult Participants
- First Posted Date
- 2023-05-10
- Last Posted Date
- 2024-10-16
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 12
- Registration Number
- NCT05852340
- Locations
- 🇧🇪
Pfizer Clinical Research Unit - Brussels, Brussels, Bruxelles-capitale, Région DE, Belgium
A Study to Assess the Safety, Tolerability, and Immunogenicity of RSVpreF in Adults at High Risk of Severe RSV Disease
- Conditions
- Interventions
- First Posted Date
- 2023-05-06
- Last Posted Date
- 2024-04-09
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 886
- Registration Number
- NCT05842967
- Locations
- 🇺🇸
North Alabama Research Center, Athens, Alabama, United States
🇺🇸HOPE Research Institute, Tempe, Arizona, United States
🇺🇸Institute of Human Virology (IHV), Baltimore, Maryland, United States
A Study to Learn About the Effects of Medicines That Help in Thinning the Blood in People With Atrial Fibrillation (AF) Between 2016 and 2020 in France
- Conditions
- Interventions
- First Posted Date
- 2023-05-01
- Last Posted Date
- 2024-05-17
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 3691397
- Registration Number
- NCT05838664
- Locations
- 🇫🇷
Pfizer Investigational Site, Paris, France